Koninklijke Philips N.V. (RYLPF)
Koninklijke Philips N.V. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Amsterdam, NH, NL. The stock last traded at $27.58, up 2.43% on the session, giving a market capitalisation of $26.96B. On trailing twelve-month figures it carries a trailing P/E of 19.82, a net margin of 6.3%. Its beta of 0.92 implies it has historically moved less than the broad market.
Koninklijke Philips N.V. functions as a prominent health technology enterprise, serving markets globally with a significant presence in North America. Its operations are structured around three core segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within its Diagnosis & Treatment division, the company offers a comprehensive array of diagnostic imaging solutions, encompassing advanced magnetic resonance imaging (MRI), computed tomography (CT) systems, X-ray systems, and sophisticated detector-based spectral CT solutions, alongside molecular and hybrid imaging technologies for nuclear medicine. This segment also supplies integrated interventional systems and a range of echography solutions critical for diagnosis, treatment planning, and guidance across cardiology, general imaging, obstetrics/gynecology, and point-of-care scenarios. Furthermore, it provides proprietary software to facilitate diagnostic and interventional practices, coupled with enterprise diagnostic informatics products and services. The Connected Care segment focuses on delivering solutions for acute patient management, emergency care, and sleep and respiratory care needs. It additionally develops electronic medical record (EMR) and comprehensive care management platforms. Moreover, its Personal Health division addresses consumer well-being through offerings such as electric toothbrushes, replacement brush heads, and oral hygiene products, including those for interdental cleaning and teeth whitening. This segment also extends to solutions for infant feeding and digital parenting, as well as male grooming and beauty-focused products. Philips maintains key strategic alliances, notably a collaboration with Ibex Medical Analytics Ltd., working together to globally advance digital pathology and AI-driven solutions for hospitals, healthcare networks, and pathology laboratories. The company also holds a strategic partnership with NICO.LAB. Established in 1891, the firm was formerly known as Koninklijke Philips Electronics N.V. before officially adopting its current name, Koninklijke Philips N.V., in May 2013. Its corporate headquarters are located in Amsterdam, the Netherlands.
Koninklijke Philips N.V. is most often compared with the following Healthcare names: